137 related articles for article (PubMed ID: 7478023)
1. The practitioner, the patient, the resident, and the pharmaceutical "gift".
Harlass FE; Uharriet P; Sakakini J
Mil Med; 1995 Sep; 160(9):A10. PubMed ID: 7478023
[No Abstract] [Full Text] [Related]
2. Medical professionalism in a commercialized health care market.
Relman AS
JAMA; 2007 Dec; 298(22):2668-70. PubMed ID: 18073363
[No Abstract] [Full Text] [Related]
3. Low-key, low-cost 'education' for physicians sparks savings.
Montague J
Hosp Health Netw; 1993 Jun; 67(11):70. PubMed ID: 8499972
[No Abstract] [Full Text] [Related]
4. Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries.
Singh P; Forman H; Adamson AS; Mostaghimi A; Ogdie AR; Oganisian A; Barbieri JS
J Gen Intern Med; 2019 Feb; 34(2):176-178. PubMed ID: 30324292
[No Abstract] [Full Text] [Related]
5. Margaret McCartney: Second use patents--why do we have to prescribe branded Lyrica for pain?
McCartney M
BMJ; 2015 May; 350():h2734. PubMed ID: 25995105
[No Abstract] [Full Text] [Related]
6. Concentration of Opioid-Related Industry Payments in Opioid Crisis Areas.
Lee AJ; Bandari J; Macleod LC; Davies BJ; Jacobs BL
J Gen Intern Med; 2019 Feb; 34(2):187-189. PubMed ID: 30402818
[No Abstract] [Full Text] [Related]
7. Economics is everybody's business.
Riesenberg D
JAMA; 1989 Nov; 262(20):2897. PubMed ID: 2810628
[No Abstract] [Full Text] [Related]
8. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
9. [Diuretics and electrolytes].
Ritz E; Frey FJ
Ther Umsch; 2000 Jun; 57(6):343-4. PubMed ID: 10894016
[No Abstract] [Full Text] [Related]
10. Clinical decision making: from theory to practice. Three battles to watch in the 1990s.
Eddy DM
JAMA; 1993 Jul; 270(4):520-6. PubMed ID: 8320794
[No Abstract] [Full Text] [Related]
11. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
12. Changing clinical practice: messages, messengers, and methods.
Stuart ME
HMO Pract; 1996 Sep; 10(3):100-2. PubMed ID: 10160283
[No Abstract] [Full Text] [Related]
13. [Medical economics in year 2001 as exemplified by Helicobacter pylori].
Oberender P; Heissel A
Internist (Berl); 2001 Apr; 42(4):465-9, 471-2. PubMed ID: 11326729
[No Abstract] [Full Text] [Related]
14. Medical education and professionalism.
Lancet; 2009 Mar; 373(9668):980. PubMed ID: 19303999
[No Abstract] [Full Text] [Related]
15. Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries.
Mitchell AP; Winn AN; Dusetzina SB
JAMA Intern Med; 2018 Jun; 178(6):854-856. PubMed ID: 29630687
[TBL] [Abstract][Full Text] [Related]
16. Doctors no longer need medical secretaries.
Spence D
BMJ; 2013 Jan; 346():f226. PubMed ID: 23315258
[No Abstract] [Full Text] [Related]
17. Sources of the growth in Medicare physician expenditures.
Berenson R; Holahan J
JAMA; 1992 Feb; 267(5):687-91. PubMed ID: 1731136
[No Abstract] [Full Text] [Related]
18. Changing complexities of challenges for clinical practice.
Moore A; Jull G
Man Ther; 2010 Dec; 15(6):513. PubMed ID: 20965429
[No Abstract] [Full Text] [Related]
19. Economics in epilepsy treatment choices: our certain fate?
Heaney DC; Beran RG; Halpern MT
Epilepsia; 2002; 43 Suppl 4():32-8. PubMed ID: 12059999
[No Abstract] [Full Text] [Related]
20. "Better" (sometimes) in vascular disease management.
Lawrence PF
J Vasc Surg; 2016 Jan; 63(1):260-9. PubMed ID: 26718826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
